Prophase labs, inc. (PRPH)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-809

-467

-428

-1,238

-1,013

-467

-1,057

-259

43

-216

-777

-2,306

43,888

-572

167

-1,127

-1,336

-1,256

602

-1,566

-1,380

-676

-3,216

-3,138

-804

598

1,236

-1,719

290

452

1,074

-1,929

-688

-1,833

1,110

-974

-1,013

Adjustments to reconcile net loss to net cash provided by operating activities:
Realized loss on marketable debt securities

-3

-8

0

-1

-3

3

-33

-85

-15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on sale of assets, net of taxes

-

-

-

-

-

-

-

-

-

-

-295

-584

43,268

0

0

0

0

0

0

4

5

0

6

0

0

-

-

-

-

-

-

-

-

0

0

0

28

Change in valuation allowance, income tax

-

-

-

-

-

-

-

-

-

2,743

-295

-1,480

453

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

82

96

100

101

101

96

97

95

95

-188

106

96

323

-

-

106

107

-

93

84

83

-

-

-

-

-

58

58

62

-

67

63

58

58

103

97

97

Lower of cost or net realizable value inventory adjustment

-12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of loan origination and warrant expenses

-

-

-

-

-

-

-

-

-

-

-

0

-10

-6

-6

-6

-6

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

198

188

180

180

196

201

199

203

31

32

28

18

0

0

0

0

1

34

33

34

34

853

63

64

64

123

67

40

39

38

45

75

88

315

125

107

84

Changes in operating assets and liabilities:
Accounts receivable

-797

549

745

-50

-2,180

1,917

-312

-421

-161

832

-722

-1,575

-2,360

1,937

2,032

-887

-1,312

1,234

1,521

-2,223

-2,368

1,785

1,708

-513

-2,463

874

3,317

-1,952

-2,329

1,200

3,271

-1,604

-677

-1,200

3,257

-1,346

-2,313

Inventory

256

-427

-140

415

-292

-814

331

376

479

-461

26

-189

-581

-1,462

-151

277

-259

-560

1,186

428

-15

-888

932

1,036

-309

-752

-15

1,141

96

-1,363

273

530

-77

-830

1,924

250

-338

Prepaid and other assets

-64

10

191

-115

-78

-57

4

-212

80

-87

-281

251

-82

-1,204

703

-703

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

263

-184

127

222

-179

170

-76

-201

-18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

357

-1,597

188

596

-190

572

71

273

-585

564

-1,441

709

407

-19

-287

271

349

-618

759

11

-296

-63

159

595

-183

-175

Accrued advertising and other allowances

-

-

-

-

-

-

-

-

-

-1,088

-263

-216

-1,038

507

411

-306

-315

380

-169

-935

-453

519

88

196

35

154

509

-336

-240

617

256

-545

-527

40

1,117

-952

-770

Other current liabilities

-69

25

-72

55

-255

416

-651

-95

105

-71

33

-3,868

2,418

-

618

-993

397

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets held for sale, discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-405

699

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other operating assets and liabilities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-806

1,340

225

-906

568

1,086

-938

-839

561

2,099

-561

-2,011

328

640

-84

-1,153

-1,032

1,463

-160

-352

Accrued sales allowance, discontinued operations

-

-

-

-

-

-

-

44

-61

-

-

-

400

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets held for sale

-

-

-

-

-

0

0

0

-22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

285

-428

-889

-927

1,403

-781

-1,301

129

-166

-1,726

-445

-3,674

3,007

398

-682

-1,191

1,003

-1,012

-3,215

-1,402

2,132

-

-

-

-

-

-

-

-

-

-2,694

-1,474

775

-

-3,594

-649

1,198

Cash flows from investing activities
Net proceeds from the sale of assets

-

-

-

-

-

-

-

-

-

0

0

0

40,825

0

0

0

0

0

0

4

5

0

6

0

0

-

-

-

-

-

-

-

-

0

0

0

166

Purchase of marketable securities

706

-

-

-

-

1,316

2,445

3,825

5,764

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable debt securities

800

-

-

-

2,470

0

2,350

6,235

5,695

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable debt securities

-

-

-

-

-

1,497

0

9,124

450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures

116

-

-

-

48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,951

-

-3,260

-236

3,777

-

-

-

-

-

-

-

-

Capital expenditures

-

-

-

-

-

-

-

-

-

6

70

90

42

232

92

117

210

40

250

386

42

190

44

61

17

118

74

242

8

-23

101

184

48

12

84

194

10

Net cash provided by (used in) investing activities

-22

2,787

808

-474

2,422

66

-95

11,510

381

4,827

-23,746

-90

40,783

-232

-92

-117

-210

-40

-250

-382

-37

-

-

-

-

-

-

-

-

-

-101

-184

-48

-

-84

-194

156

Cash flows from financing activities
Payment of dividends

-

2,893

0

0

2,929

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to retire notes

-

-

-

-

-

-

-

-

-

0

0

0

1,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds for warrants exercised

-

-

-

-

-

-

-

-

-

0

-102

102

69

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

83

3,879

947

249

0

0

195

1,070

0

0

0

-

-

-

-

Net cash used in financing activities

-

-2,893

0

0

-2,929

-

-

-

-

-3,825

-9,192

-1,756

-1,431

-100

0

0

0

-

-

-

-

-99

83

4,843

-17

695

-74

-242

-8

-310

0

0

0

-

-

-

-

Increase in cash and cash equivalents

263

-534

-81

-1,401

896

-715

-1,396

277

215

-724

-33,383

-5,520

42,359

66

-774

-1,308

793

328

-2,425

-1,260

2,095

-2,027

-2,397

1,831

3,881

887

-3,307

-478

3,964

-1,243

-2,795

-1,658

727

925

-4,127

-843

1,354

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

947

-

27

0

195

-

-

-

-

-

-

-

-

Supplemental disclosures:
Cash paid for interest

-

-

-

-

-

-

-

-

-

0

0

0

54

95

0

95

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Unrealized gain on marketable debt securities

11

4

-5

8

15

0

29

68

-43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in escrow receivable

-

-

-

-

-

-

-

-

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Escrow receivable

-

-

-

-

-

-

-

-

-

-

-

-

5,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-